KLOW best for: reactive or redness-prone skin, active rosacea or inflammatory acne, post-procedure recovery (laser, microneedling), chronic low-grade facial inflammation
Theoretical angiogenic risk in patients with active malignancy or high oncological risk warrants direct oncological consultation before use
Journal of Clinical Investigation, 112(3), 567-574
Tirzepatide SURMOUNT and SURPASS trial results Tirzepatide has been studied extensively in the SURMOUNT program for weight management and SURPASS program for type 2 diabetes
Addendum D1 can also be found via the internet on the CMS website
Its mechanism involves inhibiting palmitoylation of 1-adrenergic receptor (1AR), which activates downstream effector molecules and mediates phenylephrine-induced renal artery vasoconstriction (166)